PMC:1974816 / 12826-13456 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/1974816","sourcedb":"PMC","sourceid":"1974816","source_url":"https://www.ncbi.nlm.nih.gov/pmc/1974816","text":"One of the thalidomide studies (23) has been omitted from this analysis because the response rate reported was the best M-protein response within 60 d of starting treatment with thalidomide. Because some responses will have occurred after day 60, this measure is not comparable with those used in the other thalidomide studies. Indeed, the reported response rate in this study (17%, 20/120) was lower than the M-protein response rates reported in the other thalidomide studies (Fig. 3). Including the response rate reported from this study would have produced a biased, low, estimated response rate for treatment with thalidomide.","tracks":[]}